Which region held the largest market share in the Castration-Resistant Prostate Cancer (CRPC) Treatment Market market?

North America is the region to held the largest market share with 47% growth. Read More

Who are the key players in the Castration-Resistant Prostate Cancer (CRPC) Treatment Market market?

Active Biotech AB, Allarity Therapeutics Inc., Amgen Inc., Amneal Pharmaceuticals Inc., Astellas Pharma Inc., Bayer AG, BeiGene Ltd., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories .... Read More

Which Segment has the largest market share in the Castration-Resistant Prostate Cancer (CRPC) Treatment Market market?

Distribution Channel is the segment that has the largest market share in the market. Read More

Castration-Resistant Prostate Cancer (CRPC) Treatment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Q: How much is the Castration-Resistant Prostate Cancer (CRPC) Treatment Market market?

The castration-resistant prostate cancer (crpc) treatment market market size is estimated to grow at $$ 5.98 bn in 2023. Read More

Q: What is the growth rate of the Castration-Resistant Prostate Cancer (CRPC) Treatment Market market?

The growth rate of the castration-resistant prostate cancer (crpc) treatment market year-over-year is 8.83%. Read More

Published: Dec 2023
Pages: 160
SKU: IRTNTR77080

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Therapy
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global castration-resistant prostate cancer (CRPC) treatment market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global castration-resistant prostate cancer (crpc) treatment market 2018 - 2022 ($ billion)

4.2 Distribution Channel Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ billion)

4.3 Therapy Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Therapy Segment 2018 - 2022 ($ billion)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

6.1 Market segments
- Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)

6.2 Comparison by Distribution Channel
- Exhibit 32: Chart on Comparison by Distribution Channel
- Exhibit 33: Data Table on Comparison by Distribution Channel

6.3 Hospital pharmacies - Market size and forecast 2023-2028
- Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)

6.4 Retail pharmacies - Market size and forecast 2023-2028
- Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)

6.5 Online pharmacies - Market size and forecast 2023-2028
- Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by Distribution Channel
- Exhibit 46: Market opportunity by Distribution Channel ($ billion)
- Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Therapy

7.1 Market segments
- Exhibit 48: Chart on Therapy - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Therapy - Market share 2023-2028 (%)

7.2 Comparison by Therapy
- Exhibit 50: Chart on Comparison by Therapy
- Exhibit 51: Data Table on Comparison by Therapy

7.3 Hormonal therapy - Market size and forecast 2023-2028
- Exhibit 52: Chart on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 53: Data Table on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 54: Chart on Hormonal therapy - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Hormonal therapy - Year-over-year growth 2023-2028 (%)

7.4 Chemotherapy - Market size and forecast 2023-2028
- Exhibit 56: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)

7.5 Others - Market size and forecast 2023-2028
- Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by Therapy
- Exhibit 64: Market opportunity by Therapy ($ billion)
- Exhibit 65: Data Table on Market opportunity by Therapy ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 67: Chart on Market share by geography 2023-2028 (%)
- Exhibit 68: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 China - Market size and forecast 2023-2028
- Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)

9.9 Canada - Market size and forecast 2023-2028
- Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.10 Germany - Market size and forecast 2023-2028
- Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.11 UK - Market size and forecast 2023-2028
- Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 107: Market opportunity by geography ($ billion)
- Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption

11.4 Industry risks
- Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 113: Vendors covered

12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification

12.3 Active Biotech AB
- Exhibit 115: Active Biotech AB - Overview
- Exhibit 116: Active Biotech AB - Product / Service
- Exhibit 117: Active Biotech AB - Key offerings

12.4 Allarity Therapeutics Inc.
- Exhibit 118: Allarity Therapeutics Inc. - Overview
- Exhibit 119: Allarity Therapeutics Inc. - Product / Service
- Exhibit 120: Allarity Therapeutics Inc. - Key offerings

12.5 Amgen Inc.
- Exhibit 121: Amgen Inc. - Overview
- Exhibit 122: Amgen Inc. - Product / Service
- Exhibit 123: Amgen Inc. - Key offerings

12.6 Amneal Pharmaceuticals Inc.
- Exhibit 124: Amneal Pharmaceuticals Inc. - Overview
- Exhibit 125: Amneal Pharmaceuticals Inc. - Business segments
- Exhibit 126: Amneal Pharmaceuticals Inc. - Key news
- Exhibit 127: Amneal Pharmaceuticals Inc. - Key offerings
- Exhibit 128: Amneal Pharmaceuticals Inc. - Segment focus

12.7 Astellas Pharma Inc.
- Exhibit 129: Astellas Pharma Inc. - Overview
- Exhibit 130: Astellas Pharma Inc. - Product / Service
- Exhibit 131: Astellas Pharma Inc. - Key news
- Exhibit 132: Astellas Pharma Inc. - Key offerings

12.8 Bayer AG
- Exhibit 133: Bayer AG - Overview
- Exhibit 134: Bayer AG - Business segments
- Exhibit 135: Bayer AG - Key news
- Exhibit 136: Bayer AG - Key offerings
- Exhibit 137: Bayer AG - Segment focus

12.9 BeiGene Ltd.
- Exhibit 138: BeiGene Ltd. - Overview
- Exhibit 139: BeiGene Ltd. - Business segments
- Exhibit 140: BeiGene Ltd. - Key offerings
- Exhibit 141: BeiGene Ltd. - Segment focus

12.10 Dr Reddys Laboratories Ltd.
- Exhibit 142: Dr Reddys Laboratories Ltd. - Overview
- Exhibit 143: Dr Reddys Laboratories Ltd. - Business segments
- Exhibit 144: Dr Reddys Laboratories Ltd. - Key offerings
- Exhibit 145: Dr Reddys Laboratories Ltd. - Segment focus

12.11 F. Hoffmann La Roche Ltd.
- Exhibit 146: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 147: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 148: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 149: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 150: F. Hoffmann La Roche Ltd. - Segment focus

12.12 Johnson and Johnson
- Exhibit 151: Johnson and Johnson - Overview
- Exhibit 152: Johnson and Johnson - Business segments
- Exhibit 153: Johnson and Johnson - Key news
- Exhibit 154: Johnson and Johnson - Key offerings
- Exhibit 155: Johnson and Johnson - Segment focus

12.13 Merck KGaA
- Exhibit 156: Merck KGaA - Overview
- Exhibit 157: Merck KGaA - Business segments
- Exhibit 158: Merck KGaA - Key news
- Exhibit 159: Merck KGaA - Key offerings
- Exhibit 160: Merck KGaA - Segment focus

12.14 Novartis AG
- Exhibit 161: Novartis AG - Overview
- Exhibit 162: Novartis AG - Business segments
- Exhibit 163: Novartis AG - Key offerings
- Exhibit 164: Novartis AG - Segment focus

12.15 Ono Pharmaceutical Co. Ltd.
- Exhibit 165: Ono Pharmaceutical Co. Ltd. - Overview
- Exhibit 166: Ono Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 167: Ono Pharmaceutical Co. Ltd. - Key offerings

12.16 Pfizer Inc.
- Exhibit 168: Pfizer Inc. - Overview
- Exhibit 169: Pfizer Inc. - Product / Service
- Exhibit 170: Pfizer Inc. - Key news
- Exhibit 171: Pfizer Inc. - Key offerings

12.17 Sanofi SA
- Exhibit 172: Sanofi SA - Overview
- Exhibit 173: Sanofi SA - Business segments
- Exhibit 174: Sanofi SA - Key news
- Exhibit 175: Sanofi SA - Key offerings
- Exhibit 176: Sanofi SA - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 177: Inclusions checklist
- Exhibit 178: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 179: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 180: Research methodology
- Exhibit 181: Validation techniques employed for market sizing
- Exhibit 182: Information sources

13.5 List of abbreviations
- Exhibit 183: List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES